Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

David M. Kurtz, Florian Scherer, Michael C. Jin, +24

Journal of Clinical Oncology

Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA

Florian Scherer, David M. Kurtz, Aaron M. Newman, +19

Science Translational Medicine

EngineeringCtdna GenotypingGeneticsPathologyGenomics +17

Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study

Alison R. Sehgal, Daanish Hoda, Peter A. Riedell, +19

The Lancet Oncology

Hematological MalignancyLymphoid NeoplasiaTransplantationMarrow TransplantationLisocabtagene Maraleucel +8

How I treat CNS lymphomas

James L. Rubenstein, Neel K. Gupta, Gabriel N. Mannis, +2

Blood

Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology

Erin Reid, Gita Suneja, Richard F. Ambinder, +25

Journal of the National Comprehensive Cancer Network

Long-term survival in AIDS-related primary central nervous system lymphoma

Neel K. Gupta, Amber Nolan, Antonio Omuro, +14

Neuro-Oncology

AIDS-Related Kaposi Sarcoma, Version 2.2019

Erin Reid, Gita Suneja, Richard F. Ambinder, +26

Journal of the National Comprehensive Cancer Network

CD20-Targeted Therapy Ablates <i>De Novo</i> Antibody Response to Vaccination but Spares Preestablished Immunity

Tanaya Shree, Vishnu Shankar, Julian J.K. Lohmeyer, +14

Blood Cancer Discovery

Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial

Matthew J. Frank, Michael S. Khodadoust, Debra K. Czerwinski, +21

The Journal of Experimental Medicine

Cell TherapyImmunologyImmunoeditingFavorable Clinical OutcomesCd4 T Cell Responses +17

Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999–2008 and treated with curative intent in the AIDS Malignancy Consortium

Ulas D. Bayraktar, Juan Carlos Ramos, Adam M. Petrich, +11

Leukemia & lymphoma/Leukemia and lymphoma

Cell TherapyImmunodeficienciesImmunologyImmunotherapyCurative Intent +14